RecruitingNCT06454396

Effectiveness and Health Economics of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure

A Real-world Clinical Study Based on a Decentralized Arteriovenous Endovascular Fistula Data System - Effectiveness and Health Economics of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure


Sponsor

RenJi Hospital

Enrollment

480 participants

Start Date

Jan 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This study was aimed at evaluating the efficacy of different endovascular treatments for early and mid-stage clinical interventions in patients with autologous arteriovenous fistulae loss of function and the corresponding health economic value.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing different endovascular treatments — including balloon dilation, medicated balloons, and stent placement — for restoring blood flow through arteriovenous fistulas that have stopped working in hemodialysis patients. The fistula is an artificial connection between an artery and vein created in the arm to allow dialysis, and when it fails, patients need an intervention to restore access. Adults aged 18 to 80 who are on hemodialysis and have a failed arteriovenous fistula that requires endovascular treatment may be eligible, unless they are planning a kidney transplant or have serious additional health conditions. Participation involves receiving one of the standard endovascular treatments and being followed up at intervals of 1, 6, 12, 18, and 24 months after the procedure. This summary was prepared to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEndovascular therapy

Endovascular therapy is a minimally invasive interventional approach that utilizes the vascular system as a pathway to access and treat various pathological conditions within the body. By employing specialized catheters and devices, endovascular techniques enable precise delivery of therapeutic agents or interventional procedures directly to the target site, without the need for conventional open surgery.


Locations(1)

Renji Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06454396


Related Trials